Search Results for: hepatitis c

January 28, 2015January 28, 2015

Hepatitis C Treatment VIEKIRAX® + EXVIERA® Now EMA-Approved

News

The European Commission has granted marketing authorizations for AbbVie’s all-oral, interferon-free, short-course treatment with VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets). This treatment was recently approved with or without ribavirin (RBV) for patients suffering ... Read more

January 26, 2015January 26, 2015

Gilead’s Hepatitis C Treatment Sofosbuvir Rejected in India

News

Gilead Sciences, Inc.‘s application to commercialize novel hepatitis C treatment sofosbuvir in India has been rejected by the country’s patent office, as reported by Reuters. The refusal may open a new ... Read more

January 21, 2015January 21, 2015

Benitec Biopharma Advances Hepatitis C Clinical Trial

News

Benitec Biopharma Limited announced that it has dosed the third patient in its Phase I/IIa clinical trial with TT-034 for hepatitis C, at the Duke Clinical Research Unit (USA). This marks an ... Read more

January 20, 2015January 20, 2015

Report Indicates Higher Prescription Rates of Two Novel Hepatitis C Therapies, Increase in Treated Patients

Hepatitis C, News

Recently, the CVS Health Research Institute analyzed the rate of prescriptions for two novel hepatitis C treatments, Harvoni® (ledipasvir and sofosbuvir) and Sovaldi® (sofosbuvir) a few weeks after their respective ... Read more

January 16, 2015January 16, 2015

Patient Advocate Foundation Launches New Hepatitis C CareLine

News

The Patient Advocate Foundation (PAF) announced the launch of a new Hepatitis C CareLine to provide sustained and individualized assistance to patients diagnosed with Hepatitis C for free. PAF is a national non-profit ... Read more

January 14, 2015January 14, 2015

Hepatitis C Patients Protest Limited Access to Sofosbuvir

News

Hundreds of hepatitis C patients and respective supporters protested in Madrid last December, complaining about the cuts in public spending that have significantly reduced public access to Sovaldi (sofosbuvir), a ... Read more

January 9, 2015January 9, 2015

Hepatitis C Treatment Response Affected by Genetic Interferon Activity

Hepatitis A, News

While hepatitis A has a wide range of available treatment options, not all patients are cured of the disease. A recent study from the Aarhus University in Denmark attempted to understand this ... Read more

January 6, 2015January 6, 2015

Study Reveals Great Age and Race Disparities in Hepatitis C-Related Deaths

News

The communities with highest public health needs in the state of Massachusetts were identified by a geospatial study conducted at Tufts University School of Medicine, focused on both HIV/AIDS and hepatitis C that revealed great disparities ... Read more

January 5, 2015January 5, 2015

PCORI Board Grants $50 Million Funding for Hepatitis C Clinical Effectiveness Research

Hepatitis C, News

The Patient-Centered Outcomes Research Institute (PCORI) has granted $50 million for the development of four comparative clinical effectiveness research (CER) studies dedicated to the diagnosis and treatment of hepatitis C virus (HCV) ... Read more

December 22, 2014December 22, 2014

Viekira Pak™ From AbbVie Approved By FDA For Chronic Genotype 1 (GT1) Hepatitis C

Hepatitis C, News

Viekira Pak™ from AbbVie recently received FDA approval for the treatment of people suffering with chronic genotype 1 (GT1) hepatitis C. The recently approved Viekira, with or without ribavirin (RBV), is an oral interferon-free treatment for patients ... Read more